Mirae Asset Global ETFs Holdings
AVBP icon

Mirae Asset Global ETFs Holdings’s ArriVent BioPharma AVBP Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$404K Buy
17,726
+2,348
+15% +$53K ﹤0.01% 1990
2025
Q4 		$310K Buy
15,378
+2,132
+16% +$44.4K ﹤0.01% 2138
2025
Q3 		$244K Sell
13,246
-157
-1% -$3.08K ﹤0.01% 2226
2025
Q2 		$293K Sell
13,403
-4,143
-24% -$86K ﹤0.01% 2080
2025
Q1 		$325K Buy
17,546
+432
+3% +$10.6K ﹤0.01% 2081
2024
Q4 		$456K Buy
17,114
+1,327
+8% +$38.1K ﹤0.01% 1966
2024
Q3 		$371K Buy
15,787
+10,906
+223% +$248K ﹤0.01% 2065
2024
Q2 		$90.5K Buy
+4,881
New +$87K ﹤0.01% 2605

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mirae Asset Global ETFs Holdings's AVBP Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its ArriVent BioPharma (AVBP) stake by 15% in Q1 2026, buying an estimated $53K and bringing the position to 17,726 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

Mirae Asset Global ETFs Holdings first reported a position in AVBP in Q2 2024 and has held it in 8 quarters since. The position peaked at $456K in Q4 2024. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 17,726 shares of ArriVent BioPharma worth $404K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 2,348 ArriVent BioPharma shares in Q1 2026, an estimated $53K.
  • ArriVent BioPharma made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1990 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in ArriVent BioPharma in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's ArriVent BioPharma position peaked at $456K in Q4 2024.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.